N C C A M: The National Center for Complementary and Alternative Medicine. Expanding horizons of health care

NCCAM Web Site User Satisfaction Survey

Thank you for visiting the NCCAM Web site.

Please help us improve our site by answering a few questions. This survey will take less than 5 minutes of your time. Your responses will be kept confidential and anonymous.

Would you like to take the online survey now?

To prevent this popup window from opening again during your current visit, your response will be stored in a temporary cookie. Review our privacy policy.

Can Chelation Therapy Help Prevent Heart Attacks?
National Study Underway; Local Site Near You

NIH News Advisory—Video Alert

National Institutes of Health
U.S. Department of Health and Human Services

National Center for Complementary and Alternative Medicine (NCCAM)

For immediate release:

Wednesday, December 1, 2004

Contact:

NCCAM Press Office, 301-496-7790

Who

Assignment/News Editors/Medical Reporters

What

The National Institutes of Health (NIH) is conducting a nationwide study on the safety and effectiveness of chelation therapy, an investigational treatment for people with heart disease. Chelation therapy uses a man-made amino acid, called EDTA (ethylene diamine tetra-acetic acid), which is added to the blood through a vein. For many years, people with heart disease have considered chelation therapy, despite a lack of definitive evidence. The NIH study is the largest clinical study to be conducted on chelation therapy. It is 20 times larger than any previous study and is designed to provide the answer to this important question. Results are expected in about 5 years.

More than 100 medical institutions across the country have been selected to take part in the study. You are receiving this advisory because there is a participating local site near you. For an up-to-date list of participating sites, please visit nccam.nih.gov/chelation/studysite.htm.

This video package is produced for the National Center for Complementary and Alternative Medicine, part of the NIH, and is for free and unrestricted use in whole or part. It includes B-roll and soundbites, footage of chelation therapy and laboratory research, and soundbites with Principal Investigator Dr. Gervasio Lamas, Investigator Dr. Roy Heilbron, and chelation study participants Edward Grocki and Julio Kaufman. To view a video clip of this package, go to: NewsBroadcastNetwork.com or nccam.nih.gov/chelation.

When

Wednesday, December 8, 2004
1:00–1:15 p.m., ET
Via Satellite C-Band, IA-6
Transponder: 16
Downlink: 4020 H
Audio: 6.2 - 6.8
Technical Info DURING FEED ONLY: NBN, TOC, 212-684-8910, x 221

Free From News Broadcast Network: 212-684-8910
Hard Copy Information: Tom Hendrick, 301-229-4894
Editorial Contact: NCCAM Press Office, 301-496-7790

NCCAM is dedicated to exploring complementary and alternative healing practices in the context of rigorous science, training CAM researchers, and disseminating authoritative information to the public and professionals. For additional information, call NCCAM's Clearinghouse toll free at 1-888-644-6226 or visit NCCAM's Web site at nccam.nih.gov.